These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23136227)

  • 1. Treatment and complications in elderly stage III colon cancer patients in the Netherlands.
    Hoeben KW; van Steenbergen LN; van de Wouw AJ; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
    Ann Oncol; 2013 Apr; 24(4):974-9. PubMed ID: 23136227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.
    Kim CA; Spratlin JL; Armstrong DE; Ghosh S; Mulder KE
    Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
    Fata F; Mirza A; Craig G; Nair S; Law A; Gallagher J; Ellison N; Bernath A
    Cancer; 2002 Apr; 94(7):1931-8. PubMed ID: 11932894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
    van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
    Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients.
    van Erning FN; Razenberg LG; Lemmens VE; Creemers GJ; Pruijt JF; Maas HA; Janssen-Heijnen ML
    Eur J Cancer; 2016 Jul; 61():1-10. PubMed ID: 27128782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study].
    Mondaca S; Villalón C; Leal JL; Zúñiga Á; Bellolio F; Padilla O; Palma S; Garrido M; Nervi B
    Rev Med Chil; 2016 Feb; 144(2):145-51. PubMed ID: 27092667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
    Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
    Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
    Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
    Lonardi S; Sobrero A; Rosati G; Di Bartolomeo M; Ronzoni M; Aprile G; Massida B; Scartozzi M; Banzi M; Zampino MG; Pasini F; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Barni S; Zagonel V; Maiello E; Rulli E; Labianca R;
    Ann Oncol; 2016 Nov; 27(11):2074-2081. PubMed ID: 27573560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
    Margalit O; Mamtani R; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Eur J Cancer; 2018 Jun; 96():105-110. PubMed ID: 29698932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in elderly patients (>or=75 yr) completely resected for colon cancer stage III compared to younger patients: toxicity and prognosis.
    Jensen SA; Vilmar A; Sørensen JB
    Med Oncol; 2006; 23(4):521-31. PubMed ID: 17303911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
    Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
    Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
    van Steenbergen LN; Lemmens VEPP; Rutten HJT; Wymenga ANM; Nortier JWR; Janssen-Heijnen MLG
    Ann Oncol; 2012 Nov; 23(11):2805-2811. PubMed ID: 22562836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study).
    Kosugi C; Koda K; Ishibashi K; Yoshimatsu K; Tanaka S; Kato R; Kato H; Oya M; Narushima K; Mori M; Shuto K; Ishida H
    Int J Colorectal Dis; 2018 Jun; 33(6):809-817. PubMed ID: 29484450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.
    Aspinall SL; Good CB; Zhao X; Cunningham FE; Heron BB; Geraci M; Passero V; Stone RA; Smith KJ; Rogers R; Shields J; Sartore M; Boyle DP; Giberti S; Szymanski J; Smith D; Ha A; Sessions J; Depcinski S; Fishco S; Molina I; Lepir T; Jean C; Cruz-Diaz L; Motta J; Calderon-Vargas R; Maland J; Keefe S; Tague M; Leone A; Glovack B; Kaplan B; Cosgriff S; Kaster L; Tonnu-Mihara I; Nguyen K; Carmichael J; Clifford L; Lu K; Chatta G
    BMC Cancer; 2015 Feb; 15():62. PubMed ID: 25884851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
    Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
    Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
    PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.